Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Perceived Spasticity and Treatment Satisfaction Among Stroke Survivors Over the Course of a Complete Treatment Cycle With Botulinum Neurotoxin A (BoNT-A): an Ethnographic Study

Trial Profile

Perceived Spasticity and Treatment Satisfaction Among Stroke Survivors Over the Course of a Complete Treatment Cycle With Botulinum Neurotoxin A (BoNT-A): an Ethnographic Study

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 10 Jun 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Botulinum-Toxin-A (Primary)
  • Indications Muscle spasticity
  • Focus Therapeutic Use
  • Acronyms REBOT
  • Sponsors Ipsen

Most Recent Events

  • 22 Apr 2021 Results assessing changes in symptom burden and their effects/interference on patient functioning and quality of life throughout the duration of a botulinum toxin type A (BoNT-A) treatment cycle, presented at the 73rd Annual Meeting of the American Academy of Neurology.
  • 16 Sep 2020 Trial design presented at the 24th International Congress of Parkinson's Disease and Movement Disorders.
  • 29 May 2020 Status changed from active, no longer recruiting to completed.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top